Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acoustic Angiography for Breast Lesions
NCT03544268Phase 4Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Mar 2019
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Phase 4, open-label trial (2 arms), sponsored by UNC Lineberger Comprehensive Cancer Center. Primary endpoints: Sensitivity at 2 years and Specificity at 2 years. Started Mar 2019; status: completed.
Beyond the preview
Go deeper on NCT03544268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03544268.